$EXPO
EXPONENT INC

2023 Q3 Form 10-Q Financial Statement

#000095017023038668 Filed on August 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $133.3M $140.2M
YoY Change 2.34% 9.14%
Cost Of Revenue $8.400M $6.637M
YoY Change -30.37% -37.43%
Gross Profit $125.0M $133.6M
YoY Change 5.74% 13.33%
Gross Profit Margin 93.75% 95.27%
Selling, General & Admin $82.10M $93.40M
YoY Change 24.42% 24.95%
% of Gross Profit 65.68% 69.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.300M $2.186M
YoY Change 26.93% 29.43%
% of Gross Profit 1.84% 1.64%
Operating Expenses $99.40M $103.7M
YoY Change 16.94% 13.02%
Operating Profit $33.93M $29.88M
YoY Change -25.05% -18.63%
Interest Expense $1.900M $1.593M
YoY Change 985.71% 7485.71%
% of Operating Profit 5.6% 5.33%
Other Income/Expense, Net $84.00K $4.785M
YoY Change -100.85% -222.38%
Pretax Income $34.02M $36.25M
YoY Change -3.99% 10.5%
Income Tax $9.479M $10.51M
% Of Pretax Income 27.87% 28.98%
Net Earnings $24.54M $25.75M
YoY Change -4.73% -13.04%
Net Earnings / Revenue 18.4% 18.36%
Basic Earnings Per Share $0.48 $0.50
Diluted Earnings Per Share $0.48 $0.50
COMMON SHARES
Basic Shares Outstanding 50.85M 50.84M
Diluted Shares Outstanding 51.65M 51.69M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $137.1M $148.2M
YoY Change -17.22% -31.1%
Cash & Equivalents $137.1M $148.2M
Short-Term Investments
Other Short-Term Assets $24.50M $20.62M
YoY Change 61.81% 45.93%
Inventory
Prepaid Expenses
Receivables $181.8M $175.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $343.3M $344.6M
YoY Change 0.23% -8.51%
LONG-TERM ASSETS
Property, Plant & Equipment $76.25M $76.79M
YoY Change 19.28% 25.73%
Goodwill $8.607M $8.607M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.816M $2.341M
YoY Change 251.02% 54.11%
Total Long-Term Assets $259.1M $259.7M
YoY Change 15.6% 7.81%
TOTAL ASSETS
Total Short-Term Assets $343.3M $344.6M
Total Long-Term Assets $259.1M $259.7M
Total Assets $602.5M $604.3M
YoY Change 6.31% -2.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $19.60M $19.84M
YoY Change -26.5% -35.67%
Accrued Expenses $99.50M $93.36M
YoY Change 16.18% 49.13%
Deferred Revenue $10.49M $11.34M
YoY Change -31.11% -27.61%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $129.7M $124.5M
YoY Change 1.66% 14.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.136M $3.211M
YoY Change 61.94% -97.37%
Total Long-Term Liabilities $4.136M $3.211M
YoY Change 61.94% -97.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $129.7M $124.5M
Total Long-Term Liabilities $4.136M $3.211M
Total Liabilities $248.8M $247.2M
YoY Change 8.56% 7.02%
SHAREHOLDERS EQUITY
Retained Earnings $566.5M $555.4M
YoY Change 11.83% 12.56%
Common Stock $320.2M $317.4M
YoY Change 8.12%
Preferred Stock
YoY Change
Treasury Stock (at cost) $529.3M $512.4M
YoY Change 14.66% 28.59%
Treasury Stock Shares
Shareholders Equity $353.6M $357.1M
YoY Change
Total Liabilities & Shareholders Equity $602.5M $604.3M
YoY Change 6.31% -2.15%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $24.54M $25.75M
YoY Change -4.73% -13.04%
Depreciation, Depletion And Amortization $2.300M $2.186M
YoY Change 26.93% 29.43%
Cash From Operating Activities $22.20M $40.55M
YoY Change -26.41% -738.3%
INVESTING ACTIVITIES
Capital Expenditures $3.300M $5.448M
YoY Change -199.76% 109.06%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$3.300M -$5.448M
YoY Change -0.24% 109.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -29.60M -12.65M
YoY Change -60.6% -82.76%
NET CHANGE
Cash From Operating Activities 22.20M 40.55M
Cash From Investing Activities -3.300M -5.448M
Cash From Financing Activities -29.60M -12.65M
Net Change In Cash -10.70M 22.44M
YoY Change -77.83% -127.16%
FREE CASH FLOW
Cash From Operating Activities $22.20M $40.55M
Capital Expenditures $3.300M $5.448M
Free Cash Flow $18.90M $35.10M
YoY Change -43.54% -491.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-29
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000851520
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-18655
dei Entity Registrant Name
EntityRegistrantName
EXPONENT, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0218904
dei Entity Address Address Line1
EntityAddressAddressLine1
149 COMMONWEALTH DRIVE
dei Entity Address City Or Town
EntityAddressCityOrTown
MENLO PARK
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94025
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
326-9400
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
EXPO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50848940
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
148174000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161458000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6109000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6193000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
175830000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
170114000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
20624000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17585000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-3587000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
344628000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
349157000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76793000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
65539000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25636000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18007000
CY2023Q2 us-gaap Goodwill
Goodwill
8607000
CY2022Q4 us-gaap Goodwill
Goodwill
8607000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
52212000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
53909000
CY2023Q2 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
94067000
CY2022Q4 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
89437000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2341000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2006000
CY2023Q2 us-gaap Assets
Assets
604284000
CY2022Q4 us-gaap Assets
Assets
586662000
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
19838000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
29115000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
87609000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
105822000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
11343000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18834000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5750000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5258000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
124540000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
159029000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3211000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2355000
CY2023Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
96412000
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
91183000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23042000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13343000
CY2023Q2 us-gaap Liabilities
Liabilities
247205000
CY2022Q4 us-gaap Liabilities
Liabilities
265910000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
66000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
66000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
317346000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
301002000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-3260000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
555354000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
528810000
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
14858000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15064000
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
512427000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
505539000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
357079000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
320752000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
604284000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
586662000
CY2023Q2 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
129653000
CY2022Q3 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
118218000
expo Revenue Before Reimbursements
RevenueBeforeReimbursements
258358000
expo Revenue Before Reimbursements
RevenueBeforeReimbursements
236088000
CY2023Q2 expo Revenue From Reimbursement
RevenueFromReimbursement
10568000
CY2022Q3 expo Revenue From Reimbursement
RevenueFromReimbursement
12063000
expo Revenue From Reimbursement
RevenueFromReimbursement
22172000
expo Revenue From Reimbursement
RevenueFromReimbursement
22671000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140221000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
130281000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
280530000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
258759000
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
82836000
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
58446000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
167017000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
127203000
CY2023Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
10305000
CY2022Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
8755000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
19866000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
16920000
CY2023Q2 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
10568000
CY2022Q3 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
12063000
expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
22172000
expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
22671000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6637000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5740000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12480000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9971000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
110346000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
85004000
us-gaap Operating Expenses
OperatingExpenses
221535000
us-gaap Operating Expenses
OperatingExpenses
176765000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
29875000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
45277000
us-gaap Operating Income Loss
OperatingIncomeLoss
58995000
us-gaap Operating Income Loss
OperatingIncomeLoss
81994000
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
1593000
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
175000
us-gaap Investment Income Net
InvestmentIncomeNet
3363000
us-gaap Investment Income Net
InvestmentIncomeNet
196000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4785000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10020000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9433000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13951000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6378000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9845000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12796000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13755000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
36253000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35432000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
71791000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
68239000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10505000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9677000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16919000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12875000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
25748000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
25755000
us-gaap Net Income Loss
NetIncomeLoss
54872000
us-gaap Net Income Loss
NetIncomeLoss
55364000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.5
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.5
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.06
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.5
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.05
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51255000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51890000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51193000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52154000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51692000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52394000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51694000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52725000
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.26
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.24
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.52
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.48
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
25748000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
25755000
us-gaap Net Income Loss
NetIncomeLoss
54872000
us-gaap Net Income Loss
NetIncomeLoss
55364000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-133000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1350000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
327000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1697000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-422000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7002000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23383000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1660000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25615000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24405000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
55199000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
53704000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
320752000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
580000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4205000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
460000
CY2023Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
10497000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-9920000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
100000
CY2023Q1 us-gaap Dividends
Dividends
13942000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
29124000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
341856000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
563000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2422000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-133000
CY2023Q2 us-gaap Dividends
Dividends
13377000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
25748000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
357079000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
417065000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
564000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4094000
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
48554000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-310000
CY2022Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
10200000
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-12904000
CY2022Q2 us-gaap Dividends
Dividends
13200000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
29609000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
386564000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
506000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1845000
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
63289000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1350000
CY2022Q3 us-gaap Dividends
Dividends
12537000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
25755000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
337494000
us-gaap Profit Loss
ProfitLoss
54872000
us-gaap Profit Loss
ProfitLoss
55364000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4174000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3501000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1286000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1470000
us-gaap Share Based Compensation
ShareBasedCompensation
12286000
us-gaap Share Based Compensation
ShareBasedCompensation
11467000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
21000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3163000
expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
657000
expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
219000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9116000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-582000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-16186000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-15680000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-7491000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4537000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33842000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23816000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11116000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5914000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11116000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5914000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9920000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12904000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
111843000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1243000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1070000
us-gaap Payments Of Dividends
PaymentsOfDividends
27717000
us-gaap Payments Of Dividends
PaymentsOfDividends
24859000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-36394000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-148536000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
384000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1434000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13284000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-132068000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
161458000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
297687000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148174000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165619000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22253
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6310000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12149000
CY2023Q2 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
2598000
CY2022Q3 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
4727000
expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
8349000
expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
11044000
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
161430000
CY2023Q2 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
110191000
CY2023Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
110191000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
152890000
CY2022Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
101354000
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
101354000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51255000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51890000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51193000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52154000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51692000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52394000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51694000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52725000
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
63333
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
33333
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
108140000
CY2022Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
100731000
CY2023Q2 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
110191000
CY2022Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
101354000
CY2023Q2 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
4122000
CY2022Q3 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-11259000
expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
8039000
expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-15959000
us-gaap Income Taxes Paid
IncomeTaxesPaid
16460000
us-gaap Income Taxes Paid
IncomeTaxesPaid
13763000
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
10497000
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
10200000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2110000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1950000
expo Leasehold Improvements Obtained In Exchange For Right Of Use Asset
LeaseholdImprovementsObtainedInExchangeForRightOfUseAsset
3219000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13532000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4820000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6109000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6193000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
175830000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
170114000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6193000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1286000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1370000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6109000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140221000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
130281000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
280530000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
258759000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
29875000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
45277000
us-gaap Operating Income Loss
OperatingIncomeLoss
58995000
us-gaap Operating Income Loss
OperatingIncomeLoss
81994000
CY2023Q2 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
9567000
CY2022Q3 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
4656000
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
15428000
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
7451000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2186000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1812000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4174000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3501000
CY2023Q2 expo Number Of Client Comprised More Than Ten Percent Of Revenue Or Accounts Receivable
NumberOfClientComprisedMoreThanTenPercentOfRevenueOrAccountsReceivable
0
expo Number Of Client Comprised More Than Ten Percent Of Revenue Or Accounts Receivable
NumberOfClientComprisedMoreThanTenPercentOfRevenueOrAccountsReceivable
0
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1437000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1364000
us-gaap Operating Lease Payments
OperatingLeasePayments
3801000
us-gaap Operating Lease Payments
OperatingLeasePayments
3565000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y6M
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.043
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3320000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6474000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5762000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4944000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4336000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1860000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
8098000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
34794000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6002000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
28792000
CY2023Q2 expo Concession Amount
ConcessionAmount
2000000
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-23-038668-index-headers.html Edgar Link pending
0000950170-23-038668-index.html Edgar Link pending
0000950170-23-038668.txt Edgar Link pending
0000950170-23-038668-xbrl.zip Edgar Link pending
expo-20230630.htm Edgar Link pending
expo-20230630.xsd Edgar Link pending
expo-ex31_1.htm Edgar Link pending
expo-ex31_2.htm Edgar Link pending
expo-ex32_1.htm Edgar Link pending
expo-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
expo-20230630_cal.xml Edgar Link unprocessable
expo-20230630_def.xml Edgar Link unprocessable
expo-20230630_lab.xml Edgar Link unprocessable
expo-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
expo-20230630_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending